MercoPress, en Español
Montevideo, April 3rd 2025 - 15:39 UTC
Cancer scientists in Britain are launching what they call the world's first “Darwinian” drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients.
Get our news on your inbox! Suscribe